Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1339-1346

  Schreiber, Stefan ^a   Nikolaus, Susanna ^a   Malchow, Herbert ^b   Kruis, Wolfgang ^c   Lochs, Herbert ^d   Raedler, Andreas ^e   Hahn, Eckhart G ^f   Krummenerl, Thomas ^g   Steinmann, Gerhard ^h  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Krankenhaus Leverkusen   (Germany)

^c Evangelisches Krankenhaus Koln Kalk   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Tabea Center for Inflammatory Bowel Disease   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g Gastroenterology Offices   (Germany)

^h BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGONUCLEOTIDE; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; PREDNISONE; STEROID;

ADULT; ARTHRITIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SCREENING; FEMALE; FEVER; HEADACHE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REMISSION; TREATMENT OUTCOME;

EID: 0035045185     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.24015     Document Type: Article

References (33)

1. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease
2. The sensation and regulation of interactions with the extracellular enviroment: The cell biology of lymphocyte adhesion receptors
3. Interactions between epithelial cells and T lymphocytes: Role of adhesion molecules
4. Adhesion molecules in autoimmune disease
5. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
6. Intercellular adhesion molecule 1 on liver allografts during rejection
7. Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection
8. Intercellular adhesion molecule expression in the evolving human cutaneous delayed hypersensitivity reaction
9. Immunohistochemical study of adhesion molecules in liver inflammation
10. Adhesion molecules in inflammatory bowel disease
11. Treatment of inflammatory diseases with a monoclonal antibody to intercellular adhesion molecule 1
12. The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation
13. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma
14. ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats
15. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury
16. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 [ELAM-1] or intercellular adhesion molecule-1 [ICAM-1])
17. Antisense therapeutics: Is it as simple as complementary base recognition?
18. Making sense of antisense
19. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1
20. Regulation of ICAM-1-mediated fibroblast T-cell reciprocal interaction: Implications for modulation of gut inflammation
21. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
22. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
23. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men
24. The adhesion molecules of inflammation
25. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis
26. The role of cell adhesion molecules in immunopathology
27. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease
28. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis
29. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1
30. Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury
31. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method
32. Double-blinded randomised, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS-2302 (ICAM-1 antisense) in active, steroid-dependent Crohn's disease